Therapy Areas


Established leaders in the GI therapeutic area, our PPI (Proton Pump Inhibitor) nbrands have shaped the market landscape in India. Market leaders in the Omeprazole and Rabeprazole category, the Omez (Omeprazole) and Razo (Rabeprazole) franchise feature in the Top-300 of the Indian Pharma Market(IPM).

Econorm (Saccharomyces Boulardii), a globally preferred probiotic is marketed in India exclusively by us, as preferred partners of Biocodex, the French innovator company. Addressing the diarrhea disease burden in India, Econorm features in the Top-300 of IPM.

More recently, we have forayed into the Hepatology super-specialty segment, increasing awareness about the disease and serving the needs of millions of hepatitis B patients in India. Our brands Entaliv (Entecavir) and Reviro (Tenofovir) are economical, first line of treatment options.

Click here to view the complete portfolio.

Becelac Fortz Vitamins Minerals
Becelac-PB C.Butyricium
Econorm Saccharomyces boulardii
Gutfeel Lactitol + Isabgul
Kinpride Cinitapride
Klap Ofloxacin + Ornidazole
Leon-Oz Levofloxacin + Ornidazole
Morease Mebeverine
Morease-I Mebeverine Hydrochloride + Plantago Ovata
Omez Omeprazole
Omez-D Omeprazole + Domperidone
Ordent Ofloxacin + Ornidazole
Pegred Polyethylene Glycol
Pegred-C Polyethylene Glycol
Razo Rabeprazole
Razo-D Rabeprazole + Domperidone
Razo-L Levosulpiride + Rabeprazole
Rebalanz Oral Electrolytes
Redotil Racecadotril
Riflux Antacid
Sibofix Rifaximin
Sparacid Sucralfate
Vegaz-OD Mesalazine
Zovanta Pantoprazole
Zovanta-D Pantoprazole + Domperidone
Entaliv Entecavir
Reviro Tenofovir Disoproxil
Viboliv Metadoxine


Cancer is a disease that requires specialized treatment and care at every stage. Our understanding of this fact can be seen in our broad range of high-quality cancer care medications. Across the spectrum of cytotoxics, targeted therapies and supportive care, our range is designed to effectively combat cancer and the side effects associated with the therapy. Grafeel (Filgrastim injection), world’s first recombinant human GCSF biosimilar protein in the field of cancer and Reditux (Rituximab injection), world's first bio-similar therapeutic monoclonal antibody have shaped the treatment landscape in India. Peggrafeel (Pegfilgrastim injection), world’s only single source pegfilgrastim is a market leader in the segment.

Click here to view the complete portfolio.

Blaztere Zoledronic Acid
Calcium Folinate Calcium Folinate
Capibine Capcetabine
Carboplatin Carboplatin
Cisplatin Cisplatin
Cytogem Gemcitabine
Dacotin Oxaliplatin
Docetere Docetaxel
Doxorubicin Doxorubicin
Empov Aprepitant
Epirubicin Epirubicin
Glioz Temozolamide
Grafeel Filgrastim
Irnocam Irnotecan
L - Asparaginase L - Asparaginase
Lenangio Lenalidomide
Levin Imatinib
Mitotax Paclitaxel
Myezom Bortizomib
Palzen Palnesetron
Peg Grafeel Peg Gcsf
Pemgem Pemetrexed
Purplz Bendamustine
Reditux Rituximab
Thaangio Thalidomide
Tyrokinin Erlotinib
Verz Voriconazole
Vincristine Vincristine
Xefta Gefitinib

Pain Management+

Our pain management portfolio addresses a whole spectrum of pain conditions.

Launched in 1995, Nise (Nimesulide), our legendary pain brand set a benchmark in its category. It features in the Top-300 of the Indian Pharma Market(IPM).

Launched in 1991, the Ketorol (Ketorolac) franchisee is the most prescribed dental pain management brand in India.

Durolane (Hyaluronic Acid) is our differentiated launch in the pain management portfolio. A single injection treatment to relieve the pain of knee or hip osteoarthritis, Durolane was launched in an exclusive partnership with Smith & Nephew. It is based upon a natural, safe and proven technology called NASHA (Non-Animal Stabilised Hyaluronic Acid).

Click here to view the complete portfolio.

Affen-Plus Aceclofenac + Paracetamol
Celadrin Cetylmyristate Oleate + Doconexent + Icosapent
Etura Etodolac
Flurish Ibandronic Acid
Hilin Diacerein
Hilin-Ace Aceclofenac + Diacerein
Hilin-Gm Diacerein + Glucosamine
Ibuclin Ibuprofen + Paracetamol
Instrel Paracetamol + Tramadol
Ketorol Ketorolac
Nicetamol Paracetamol
Nise Nimesulide
Nise-MR Nimesulide + Tizanidine
Retoz Etoricoxib
Supamove Diclofenac + Thiocolchicoside
Triozac Calcitriol Comb
Durolane Hyaluronic Acid


India is experiencing a surge in the incidence of cardiovascular diseases. Addressing the increasing disease burden, we have built major brands – Stamlo (Amlodipine) and Stamlo Beta (Amlodipine + Atenolol), both of which feature in the Top-300 of the Indian Pharma Market (IPM). We were the first ones to enter the (Angiotensin Converting Enzyme) inhibitor market in 1989 with the launch of Enam (Enalapril).

Since compliance is critical to BP control, we have introduced Activ range (monthly pack) for our prominent hypertension brands - Atocor (Atorvastatin) and Telsartan (Telmisartan). An innovative packaging concept, it helps in driving adherence to therapy.

Optidoz is our low dose combination of three anti-hypertensive drugs (Amlodipine 2.5 mg, Telmisartan 20 mg and Hydrochlorothiazide 6.25 mg) in a single pill. A first-of-its-kind approach to hypertension therapy, Optidoz controls hypertension with reduced side effects. The pill has simplified the traditional step-care treatment approach clinicians typically follow for hypertension management.

Click here to view the complete portfolio.

Atocor Atorvastatin
Atocor-E Atorva + Ezetemibe
Atocor-F Fenofibrate + Atorvastatin
Betaone-XL Metoprolol
Cardiopril Ramipril
Cardiopril-H Ramipril + Hydrochlorthiazide
Enam Enalapril
Fondared Fondaparinux Sodium
Met-Stamlo Amlodipine + Metoprolol
Olsertain Olmesartan
Olsertain-AM Amlodipine + Olmesartan
Olsertain-H Hydrochlorthiazide + Olmesartan
Optidoz Amlodipine + Hydrochlorothiazide + Telmisartan
Plagril Clopidogrel
Plagril-A Aspirin + Clopidogrel
Rozat Rosuvastatin
Rozat-F Rosuvastatin + Fenofibrat
Stamace Amlodipine + Ramipril
Stamlo Amlodipine
Stamlo Beta Atenolol + Amlodipine
Stamlo D Amlodipine + Hydrochlorothiazide
Stamlo-T Amlodipine + Telmisartan
Telsartan Telmisartan
Telsartan-AM Amlodipine + Telmisartan
Telsartan-H Telmisartan + Hydrochlorothiazide
Telsartan-Trio Amlodipine + Hydrochlorothiazide + Telmisartan


Experiencing rapid urbanization, demographic transition and lifestyle modifications, diabetes has reached epidemic proportions in India. It is a chronic condition in which adherence to therapy is very critical.

Fulfilling the unmet need for a patient-friendly dosage form, small enough to enable easy swallowing, Metsmall (Metformin Hydrochloride Sustained Release Tablet 500 mg and 1000 mg) is our differentiated offering in the diabetes portfolio. A smaller size pill than the conventional, much larger Metformin, Metsmall is a unique innovation that delivers the same efficacy or bioequivalence.

The Glimy (Glimepride) franchise is also steadily growing, and is one of the top three Glimeprides selling in India. Consolidating our diabetes portfolio are other critical brands such as Reclide (Gliclazide) and Reclimet (Gliclazide+Metformin).

Click here to view the complete portfolio.

Glimy Glimepride
Glimy-M Glimepiride + Metformin
Glimy-MP Pioglitazone + Metformin + Glimepride
Metsmall Metformin
Reclide Gliclazide
Reclimet Gliclazide + Metformin
Semi Reclimet Gliclazide + Metformin
Vozuca Voglibose
Vozuca-M Metformin + Voglibose


Factors such as appearance consciousness, high incidence of skin diseases and increasing disposable incomes are driving people to seek appropriate medical solutions for hair and skin related disorders. The dermatology market in India is growing fast, and we are trying to keep pace.

Minoxidil is the most preferred molecule amongst dermatologists for treatment of androgenetic alopecia. Mintop – our Minoxidil brand is a segment leader in the category. It also features in the Top-300 of the Indian Pharma Market (IPM). More recently we have launched a foam formulation of minoxidil for patient convenience / ease of application. Supportive therapy products such as Revilus add up to the hair loss portfolio.

A consumer-pull driven product, the Venusia range is our signature brand in the emollient market. The extensive range including moisturizer, lotion, intense moisturizer and bathing bar provides an end-to-end moisturizing solution.

Addressing a significant under-met patient need, we have in-licensed Melgain lotion (Decapeptide) for the treatment of vitiligo.

Click here to view the complete portfolio.

Acetec Acitretin
Antoxid HC Antioxidants
Aquaderm Body wash
Avarta Anti Aging Night Cream
Avarta SPF Anti Aging Day Cream
Avarta Under Eye Cream Under Eye Cream
Clearz Kojic Acid + Vitamin C
Clearz-MAX Fluocinolone + Hydroquinone + Tretinoin
Clearz-Ultra Kojic acid + Arbutin + Octinoxate + Mulberry extract gel
Daffy Syndet base Moisturising Bar
Ebernet Eberconazole
Ebernet-M Eberconazole + Mometasone Furoate
Execare Halometasone
Execare-F Halometasone + Fusidic Acid
Ezinapi Zinc Oxide + Cetylated Ester complex (Diaper rash cream)
Finax Finasteride
Gla-AD Emollients with Gamma Linolenic Acid + others
Gris ODT Terbinafine
Hydroheal-AM Colloidal Silver + Propylene Glycol + Carbomer
Mintop Minoxidil
Nexret Retinoic Acid
Niltan Demelanizing Agents - Night Cream
Niltan-SPF Demelanizing Agents - Day Cream
Revilus Biotin and Comb.
Salicylix Salicylic acid
Shadowz Sunscreen
Shadowz Silk Sunscreen
Ultravex Halobetasol
Ultravex-S Halobetasol+Salicylic Acid
Venusia Soap Syndet base Moisturising Bar
Venusia Soft Antipruritic Emollients
Venusia-MAX Intensive Moisturising Cream
Verz Voriconazole


Within the dental segment, we have a significant share in the Indian stomatological market.

Offering a range of specifically formulated toothpastes to combat dental sensitivity, Senquel-F and Vantej are our popular brands in the segment. While Senquel – F is the most preferred brand in its category, Vantej is a differentiated offering based on patented NovaMin technology. We are one of the few pharma corporates in India, marketing such a product.

Click here to view the complete portfolio.

Cheerio Sodium Monofluorophasphate
Clohex Chlorhexidine Gluconate
Clohex-Plus Chlorhexidine Gluconate + Fluorine Sodium Salt + Zinc Chloride
Dologel Benzalkonium Chloride + Lidocaine Hydrochloride + Salicylic Acid
Fitty Dent Carmellose + Polyvinyl Alcohol Acetate
Glizer Azadirachta Indica + Bromelains + Fluorine + Fluorine Sodium Salt + Papain
Ketorol-DT Ketorolac
Senquel Potassium Nitrate
Senquel-AD Fluorine Sodium Salt + Potassium Nitrate
Senquel-F Fluorine Sodium Phosphate + Potassium Nitrate
Stolin Strontium Chloride
Stolin-R Sodium Monofluorophasphate, Zinc Sulphate
Tinimox Amoxicillin + Tinidazole
Vantej Glycerin, PEG 400, Silica, Calcium Sodium Phosphosilicate, Sodium Lauryl Sulphate, Titanium Dioxide


Our Nephrology portfolio is characterized by Cresp - the first generic Darbepoetin Alfa in the world. The biosimilar was developed in-house, in line with our purpose of providing affordable and innovative medicines. A convenient and affordable dosage, the product addresses patient compliance need.

Click here to view the complete portfolio.

Suez Iron Sucrose Inj
Cresp Darbepoetin
Stace Emollients


Advancing age is associated with higher incidence of common urological ailments such as Benign Prostatic Hyperplasia (BPH), prostate cancer, calculi and urinary incontinence. With increasing life expectancy in India, the urological disease burden is also expected to increase.

Addressing such an impending need, we have pioneered 5-Alpha Reductase Inhibitors – Dutas (Dutasteride) franchisee - for the medical management of BPH, shaping the market landscape. We have in-licensed Pamorelin (Triptorelin Pamoate) from Debio Pharm Group, Switzerland for palliative treatment of advanced prostate cancer.

Click here to view the complete portfolio.

Alfoo Alfuzosin
Bispec Solifenacin
Dutalfa Alfuzosin + Dutasteride
Dutas Dutasteride
Dutas-T Dutasteride + Tamsulosin
Dynapres Tamsulosin
Finast Finasteride
Finast-T Finasteride + Tamsulosin
K-Cit Citric Acid + Potassium
Pamorelin LA Triptorelin Acetate
Tabi Bicalutamide
Tazzle Tadalafil
Torq Tolterodine